jocelyn maminta takes a look. for pharmaceutical giant pfizer.inside, researchers hard at work, producing much needed medication.cancer drugs, recently getting the approval of the f-d-a.earlier this month, daurismo for adults 75 years and older, diagnosed with acute myeloid leukemia. ritch hutchins:"daurismo is indicated for patients who generally are older and come up with the disease and can't endure the very harsh chemotherapy treatment that's available."ritch hutchins, executive director for oncology pharmaceutical sciences.ritch hutchins:"in the clinical trials that we've done, it showed a significant advantage in overall survival so it literally is saving lives and extending life." just weeks before, another significant f-d-a announcement, a new drug for lung cancer, lorbrena.this one for patients who are alk positive.ritch hutchins:"it's not the first alk lung cancer drug out there but this one overcomes the resistance that the other ones develop and it also treats patients whose cancer metastasizes to the